These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22018642)

  • 61. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
    Liu M; Wang F; Wang Y; Jin R
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial.
    Foster T; Budoff MJ; Saab S; Ahmadi N; Gordon C; Guerci AD
    Am J Gastroenterol; 2011 Jan; 106(1):71-7. PubMed ID: 20842109
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
    Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
    N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.
    Arad Y; Spadaro LA; Roth M; Newstein D; Guerci AD
    J Am Coll Cardiol; 2005 Jul; 46(1):166-72. PubMed ID: 15992652
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease.
    Niruban A; Myint PK; Potter JF
    Stroke; 2009 Sep; 40(9):e542. PubMed ID: 19590053
    [No Abstract]   [Full Text] [Related]  

  • 68. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Beilin LJ; Redgrave TG
    Eur J Clin Invest; 2002 Jun; 32(6):429-36. PubMed ID: 12059988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease.
    Szramka M; Harriss L; Ninnio D; Windebank E; Brack J; Skiba M; Krum H
    Int J Cardiol; 2007 Apr; 117(2):287-91. PubMed ID: 16889854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans.
    Schrage WG; Wilkins BW; Johnson CP; Eisenach JH; Limberg JK; Dietz NM; Curry TB; Joyner MJ
    J Appl Physiol (1985); 2010 Sep; 109(3):768-77. PubMed ID: 20558755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Sharman JE; Coombes JS
    J Atheroscler Thromb; 2010 Mar; 17(3):235-41. PubMed ID: 20032570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans.
    Liuni A; Luca MC; Di Stolfo G; Uxa A; Mariani JA; Gori T; Parker JD
    J Am Coll Cardiol; 2011 Jan; 57(1):93-8. PubMed ID: 21185507
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle.
    Brothers RM; Haslund ML; Wray DW; Raven PB; Sander M
    J Physiol; 2006 Dec; 577(Pt 2):727-37. PubMed ID: 16973706
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of atorvastatin on systemic and renal nitric oxide in healthy man.
    Mose FH; Larsen T; Bech JN; Pedersen EB
    Clin Exp Hypertens; 2013; 35(2):148-57. PubMed ID: 22784101
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
    Bakker-Arkema RG; Davidson MH; Goldstein RJ; Davignon J; Isaacsohn JL; Weiss SR; Keilson LM; Brown WV; Miller VT; Shurzinske LJ; Black DM
    JAMA; 1996 Jan; 275(2):128-33. PubMed ID: 8531308
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
    Antoniades C; Bakogiannis C; Tousoulis D; Reilly S; Zhang MH; Paschalis A; Antonopoulos AS; Demosthenous M; Miliou A; Psarros C; Marinou K; Sfyras N; Economopoulos G; Casadei B; Channon KM; Stefanadis C
    Circulation; 2010 Sep; 122(11 Suppl):S66-73. PubMed ID: 20837928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Age and sex influence the balance between maximal cardiac output and peripheral vascular reserve.
    Ridout SJ; Parker BA; Smithmyer SL; Gonzales JU; Beck KC; Proctor DN
    J Appl Physiol (1985); 2010 Mar; 108(3):483-9. PubMed ID: 19959767
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.
    Lins RL; Matthys KE; Billiouw JM; Dratwa M; Dupont P; Lameire NH; Peeters PC; Stolear JC; Tielemans C; Maes B; Verpooten GA; Ducobu J; Carpentier YA
    Clin Nephrol; 2004 Oct; 62(4):287-94. PubMed ID: 15524059
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
    Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.
    Fogari R; Preti P; Zoppi A; Lazzari P; Corradi L; Fogari E; Ciccarelli L; Derosa G
    Eur J Clin Pharmacol; 2006 Oct; 62(10):817-22. PubMed ID: 16896785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.